Providing Quality HIV Care

The Latest

CROI 2019
Conference Coverage

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021

Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.

By Larry Buhl
Promo Image

This Week in HIV Research: The Unsung Opportunities of Long-Acting Antiretrovirals

March 4, 2021: Improving care for PLWH in transition from incarceration; long-acting PrEP's potential in Black and Latinx communities; comorbidity rates and COVID-19 risk among PLWH; how COVID lockdowns affect the HIV epidemic.

By Barbara Jungwirth and Myles Helfand
women arm-in-arm

Among Women in the U.S., Race and Place Play an Outsized Role in New HIV Infections

Beyond the big-picture improvements, a closer look at the data reveals stark racial and geographic disparities in HIV incidence and prevalence.

By Ginger Skinner
COVID-19 mask

Where Does the Science Stand on COVID-19 Outcomes Among People Living With HIV?

The worst fears about HIV and COVID-19 don’t appear to have materialized, but concerns persist, particularly in cases where HIV treatment efficacy is suboptimal or comorbidities are present.

By Larry Buhl
doctor talking to senior patient

Older Adults Living With HIV Often Have Delayed Entry Into Care

A new study shows that almost two-thirds of older adults who were diagnosed with HIV at a Connecticut clinic were already at an advanced stage of disease progression.

By Michael Broder
human heart

Recent Research Highlights Difficulty in Measuring Heart Disease Risk for People Living With HIV

Two studies out of Europe aimed to give data on which patients with HIV benefit most from lipid-lowering medications, but they both ultimately concluded that better CVD risk-assessment tools—targeted specifically for PLWH—are needed.

By Larry Buhl
magnifying glass

This Week in HIV Research: The Importance of Challenging Our Assumptions

Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

By Barbara Jungwirth and Myles Helfand
Black hand white hand

Why White HIV Leadership Needs to Give Reins to Black Leaders

Racial and generational equity demand that leaders with “founder’s syndrome” transfer knowledge, relationships, and connections to new leaders in the movement to end HIV.

By Juan Michael Porter II
Stephaun Wallace, Ph.D., M.S., and Raniyah Copeland

“It’s About Our Community”: Newly Formed Science Initiative Aims to Center the Black Experience in HIV and COVID Care

Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

By Terri Wilder, M.S.W.
stop virus

Injectable Long-Acting PrEP Is Safe, Highly Effective in Cisgender Women

The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.

By Michael Broder

Meet the Experts

Paul E. Sax, M.D. Img
Paul E. Sax, M.D.

Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.

David Alain Wohl, M.D. Img
David Alain Wohl, M.D.

David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.